1 / 41

Case presentation

Case presentation. Int. 8831124 顏志維. Chief complaint. A 44 year old man complained right side weakness and dysphasia this morning. Patient profile. Right handed Smoker 1 pack per day > 20 years Alcohol occasionally take His mother had hypertension (HTN) No chronic drug using history.

jared
Download Presentation

Case presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case presentation Int. 8831124 顏志維

  2. Chief complaint • A 44 year old man complained right side weakness and dysphasia this morning.

  3. Patient profile • Right handed • Smoker 1 pack per day > 20 years • Alcohol occasionally take • His mother had hypertension (HTN) • No chronic drug using history

  4. Brief history • Right upper limb weakness for 1 week • Right side deviation when driving and walking • In the morning of admission, poor response was noted when talking. • Facial palsy was noted also.

  5. Physical examination • Vital signs : BT: 36.9^C PR: 65 /min RR: 18 /min BP: 136 / 79 mmHg • Consciousness : alert • Head: no trauma scar, no ecchymosis • Neck carotid artery bruit : not auditable • Chest : clear BS, no rales • Heart : regular heart beat, no murmur • Abdomen: soft, no tenderness • Peripheral pulse : strong

  6. Higher cerebral function • Judgment • Orientation • Memory • Abstract • Calculate • Generally intact

  7. Cranial nerve (CN) • CN II : visual accuracy intact • CN III, IV, VI : ocular motor intact • CN V : facial numbness nil, temporalis intact • CN VII : rightlower facial palsy • CN VIII : intact in auditory function • CN IX, X : intact • CN XI : intact

  8. Motor function • Muscle power : right 4 / left 5 • Muscle tone : no rigidity, no spasticity • Deep tendon reflex : right ++/ left ++ symmetrically • Plantar response : right down / left down

  9. Sensory function • Generally intact

  10. Dysphasia • Non-fluent, hesitant speech • Repeated a few utterances • Good comprehension • Handwriting poor

  11. Lab data • TG 158 mg/dl ; TCH 231 mg/dl • BUN / Cre 18 / 1.0 mg/dl • GLU 351 mg/dl • Na/ K 133 / 4.3 mmol/L • WBC 5.82 *10^3/ul • HbA1c 11.2 % • Stool exam : OB strong positive

  12. Impression • Acute onset right hemiparesis and motor aphasia plus facial palsy with stepwise course • Localized in frontal to pariatal cortex • Suspect stroke

  13. Chest X-ray

  14. Brain CT

  15. Transcranial Doppler, Carotid Duplex • The carotid duplex study showed neither plaques nor tortuosity. • The flow patterns were all normal. • It implies normal study.

  16. MRI DWI

  17. MRA- L’t ICA stenosis, cavernous portion

  18. Diagnosis • Neurological defect + image study proved -> cerebral infarction • Diabetes • Hyperlipidemia

  19. Stroke -U.S. Data

  20. Management of acute stroke • 1. prevent progress of present event • 2. prevent immediate complications • 3. prevent subsequent events • 4. to rehabilitate the patient

  21. As this patient Well known control diabetes and lipid • What current treatment exist? • What is the choice and their evidence?

  22. Current treatment • Medication • Antiplatelet and anticoagulant • Invasive procedure • 1. surgical (EC/IC bypass) • 2. intracranial angioplasty

  23. The EBM

  24. Warfarin (Vit. K 2,7,9,10) Protein C (Protein S) Fragmin Antithrombin III Heparin Plasmin tPA, urokinase Plasminogen

  25. aspirin ticlopidin clopidogrel

  26. Medication • Anticoagulant agents : • 1. heparin • 2. warfarin • Antiplatelet agents : • 1. aspirin • 2. ticlopidin • 3. clopidogrel • 4. dipyridamole

  27. Anticoagulant or antiplatelet ? • Aspirin superior to warfarin in death rate, cardiac event and hemorrhagic rate. (grade A) The WASID Studies 2005 Mar. NEJM • Clopidogrel was more effective than Aspirin in reducing the risk of ischaemic stroke, myocardial infarction, or vascular death. (grade A) The CAPRIE studies Lancet 1996 Nov.

  28. Ticlopidine • Ticlopidine is not more effective than aspirin but increasing TTP, neutropenia, skin rash and diarrhea rate. (Grade A) • Stroke 2000

  29. Dipyridamole • Dipyridamole and aspirin showed similar effect in reduction stroke risk (16% : 18%) and combination therapy showed more effective (37%) grade A ESPS2. J Neurol Sci 1996

  30. Medication conclusion • Dipyridamole + Aspirin > Aspirin or Dipyridamole • treatment effective for prevent stroke • Aspirin > Ticlopidine • Clopidogrel > Aspirin

  31. Other specific therapies • 1. Surgical Revascularization : • EC/IC Bypass Trial (Extracranial to Intracranial). (grade A) • 1377 patients 71 centers, 714 with medical control, while 663 receive STA-MCA bypass plus medication • Failed to show definite benefit in this study • NEJM 1985.

  32. Other specific therapies • 2. Intracranial angioplasty and Stenting • Use balloon • Use stent • Use balloon + stent • Stroke rate and their risks

  33. Intracranial Angioplasty and Stent Placement for Cerebral Atherosclerosis Grade B J Vasc Interv Radiol, January 2004

  34. Angioplasty (grade C) • Use balloon without stent : • The peri-procedural death and stroke rate was 8.3% • The annual stroke rate was 3.36% • A residual stenosis of > or =50% it was 4.5%. • American Journal of Neuroradiology, March 2005

  35. SSYLVIA Trial (grade B) • Stenting of SYmptomatic atherosclerotic Lesions in the Vertebral or Intracranial Arteries. • Enrolled symptoms attributed to a single target lesion of > 50% stenosis 61Pts • Risk: peri-procedure mortality 0% • Benefit: recurrent stroke 30 days after procedure 7.3% • Stroke 2004

  36. WINGSPAN Trial (grade B) • Combination of balloon dilatation and microstent 15 patients • Symptomatic with intracranial stenosis • All patients were either stable or improved 4 weeks after the treatment. • The Wingspan Study. Neuroradiology 2004

  37. WINGSPAN Trial (grade B) • 2005 update to this study • 45 medically refractory,>50% stenosis Pts • Peri-procedure risk: stroke and death 4.4% • Benefit : 7.1% six-month stroke and death rate.

  38. Intracranial angioplasty • Current opinion: • Apply in > 50% occlusion patients • Keep medication use • Stenting or Stenting after balloon could made acceptable risk / benefit result • Risk: 5% death or stroke • Benefit: 7% six-month stroke and death

  39. Back to our patient • Apply Aspirin and Dipyridamole • If angiography proved > 50% intracranial stenosis plus predict stroke recurrence rate was high (poor controlled DM HTN and hyperlipidemia), I would suggest angioplasty for lowering his risk of death and stroke rate.

  40. Comments • 李宜恭主任: 1. 報告時間過長,雖然資料很豐富,但無法 扼要說明主題的重點。 2. 證據等級的分類及依據,請適時加以說明。 • 劉耿彰醫師:資料內容需再消化。 • 許明欽醫師:時間控制不佳。

  41. Thanks a lot !

More Related